American Heart Journal
Volume 152, Issue 3 , Pages 434-441 , September 2006

Intracoronary infusion of autologous mononuclear bone marrow cells or peripheral mononuclear blood cells after primary percutaneous coronary intervention: Rationale and design of the HEBE trial—A prospective, multicenter, randomized trial

  • Alexander Hirsch, MD

      Affiliations

    • Department of Cardiology, Academic Medical Center, Amsterdam, The Netherlands
    • First 3 authors contributed equally to the manuscript, and their names are provided in alphabetical order.
    • ,
  • Robin Nijveldt, MD

      Affiliations

    • Department of Cardiology, VU University Medical Center, Amsterdam, The Netherlands
    • First 3 authors contributed equally to the manuscript, and their names are provided in alphabetical order.
    • ,
  • Pieter A. van der Vleuten, MD

      Affiliations

    • Department of Cardiology, University Medical Center Groningen, Groningen, The Netherlands
    • First 3 authors contributed equally to the manuscript, and their names are provided in alphabetical order.
    • ,
  • Bart J. Biemond, MD, PhD

      Affiliations

    • Department of Haematology, Academic Medical Center, Amsterdam, The Netherlands
    • ,
  • Pieter A. Doevendans, MD, PhD

      Affiliations

    • Department of Cardiology, University Medical Center Utrecht, Utrecht, The Netherlands
    • ,
  • Albert C. van Rossum, MD, PhD

      Affiliations

    • Department of Cardiology, VU University Medical Center, Amsterdam, The Netherlands
    • ,
  • Jan G. Tijssen, PhD

      Affiliations

    • Department of Cardiology, Academic Medical Center, Amsterdam, The Netherlands
    • ,
  • Felix Zijlstra, MD, PhD

      Affiliations

    • Department of Cardiology, University Medical Center Groningen, Groningen, The Netherlands
    • ,
  • Jan J. Piek, MD, PhD

      Affiliations

    • Department of Cardiology, Academic Medical Center, Amsterdam, The Netherlands
    • Corresponding Author InformationReprints requests: Jan J. Piek, MD, PhD, FESC, FACC, Department of Cardiology, Academic Medical Center, PO Box 22660, 1100 DD, Amsterdam, The Netherlands.
    • ,
  • on behalf of the HEBE investigators

Received 13 October 2005 ,Accepted 7 February 2006.

To access this article, please choose from the options below

Login to an existing account or Register a new account.

  • Purchase this article for 31.50 USD (You must login/register to purchase this article)

    Online access for 24 hours. The PDF version can be downloaded as your permanent record.

  • Subscribe to this title

    Get unlimited online access to this article and all other articles in this title 24/7 for one year.

  • Claim access now

    For current subscribers with Society Membership or Account Number.

  • Visit SciVerse ScienceDirect to see if you have access via your institution.

 Robin Nijveldt, MD was supported by a grant from The Netherlands Heart Foundation (2003B126).

 The study is financially supported by funds provided by the ICIN, the Dutch Heart Foundation, and by unrestricted grants from Biotronik, Boston Scientific, Guerbet, Guidant, Medtronic, Novartis, Pfizer, and Sanofi-Aventis.

PII: S0002-8703(06)00133-5

doi: 10.1016/j.ahj.2006.02.007

American Heart Journal
Volume 152, Issue 3 , Pages 434-441 , September 2006

Article Tools

* Image Usage & Resolution